Skye Bioscience’s Developing Treatment for Glaucoma Daily Download February 22, 2023 Share FacebookTwitterPinterestWhatsApp Embed Code Disclaimer Join us for a discussion about Skye Bioscience’s developing treatment for glaucoma using a synthetic cannabinoid. Our guest, CEO of Skye Bioscience, Punit Dhillon, breaks down this new innovation further with our guest Alicia Nieves. Related posts: Speculation Growing Over Uses for ChatGPT AI Sweater Aiming to Make Venture Capital More Accessible SEC Cracks Down on Kraken Exploring The Future Of The Metaverse Latest articles Bullish Bitcoin sentiment despite selloff Uncategorized March 5, 2025 Figure Markets launches yield-bearing stablecoin Market Movers: The Opening Bell March 5, 2025 Latest CTE research with Rachel Grashow, Director of Epidemiological Research Initiatives The Business of Sports March 5, 2025 From Hollywood Trailblazer to Cultural Icon: Vanessa Bell Calloway’s Journey to Empowerment and the “Business of Show” (Show Business). The Table March 5, 2025 Related articles Bullish Bitcoin sentiment despite selloff Uncategorized March 5, 2025 Figure Markets launches yield-bearing stablecoin Market Movers: The Opening Bell March 5, 2025 Latest CTE research with Rachel Grashow, Director of Epidemiological Research Initiatives The Business of Sports March 5, 2025